cystine has been researched along with sorafenib in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixon, SJ; Gleason, CE; Hayano, M; Lee, ED; Patel, DN; Skouta, R; Slusher, BS; Stockwell, BR; Tatonetti, NP; Thomas, AG; Welsch, M | 1 |
| Gan, B; Koppula, P; Zhuang, L | 1 |
| Chao, TI; Chen, G; Chen, LJ; Huang, CY; Wang, CY | 1 |
| Dong, X; Song, X; Wang, C; Wang, L; Wang, W; Wang, X; Wu, H; Xu, H; Zhao, L | 1 |
1 review(s) available for cystine and sorafenib
| Article | Year |
|---|---|
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
Topics: Amino Acid Transport System y+; Antineoplastic Agents; Cystine; DNA Methylation; Ferroptosis; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Glutathione; Histones; Humans; Molecular Targeted Therapy; Neoplasms; Piperazines; Signal Transduction; Sorafenib; Sulfasalazine | 2021 |
3 other study(ies) available for cystine and sorafenib
| Article | Year |
|---|---|
Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis.
Topics: 20-Hydroxysteroid Dehydrogenases; Amino Acid Transport System y+; Apoptosis; Biomarkers; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Separation; Cystine; Endoplasmic Reticulum Stress; Glutamic Acid; Humans; Iron; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Sequence Analysis, RNA; Sorafenib; Structure-Activity Relationship; Transcriptome; Up-Regulation | 2014 |
SHP-1/STAT3-Signaling-Axis-Regulated Coupling between BECN1 and SLC7A11 Contributes to Sorafenib-Induced Ferroptosis in Hepatocellular Carcinoma.
Topics: Amino Acid Transport System y+; Antiporters; Apoptosis; Beclin-1; Carcinoma, Hepatocellular; Cell Line, Tumor; Cystine; Ferroptosis; Glutamates; Humans; Iron; Liver Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Protein Tyrosine Phosphatase, Non-Receptor Type 6; RNA, Small Interfering; Sorafenib; STAT3 Transcription Factor | 2022 |
Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Topics: Cystine; Drug Resistance, Neoplasm; Ferroptosis; Fusion Regulatory Protein 1, Heavy Chain; Glutathione; Humans; Nanotechnology; Neoplasms; Phospholipid Hydroperoxide Glutathione Peroxidase; Sorafenib | 2023 |